HIMS & HERS HEALTH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
HIMS & HERS HEALTH, INC. (HIMS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $46.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-10
- HIMS & HERS HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $23.50M, a 21.93% decline year-over-year.
- HIMS & HERS HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $22.80M, a 46.48% decline year-over-year.
- HIMS & HERS HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $20.70M, a 16.87% decline year-over-year.
- HIMS & HERS HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $40.30M, a 989.19% increase year-over-year.
- HIMS & HERS HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $133.70M, a 128.55% increase from fiscal 2024.
- HIMS & HERS HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $58.50M, a 843.55% increase from fiscal 2023.
- HIMS & HERS HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $6.20M, a 1.59% decline from fiscal 2022.
- HIMS & HERS HEALTH, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $6.30M, a 50.00% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $46.30M 10-Q · filed 2026-08-10 | $67.00M derived: sum of 3 quarters · filed 2026-08-10 | $107.30M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $22.80M 10-Q · filed 2026-05-11 | $43.50M derived: sum of 2 quarters · filed 2026-05-11 | $83.80M derived: sum of 3 quarters · filed 2026-05-11 | $113.90M derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | $20.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $61.00M derived: sum of 2 quarters · filed 2026-02-23 | $91.10M derived: sum of 3 quarters · filed 2026-02-23 | $133.70M 10-K · filed 2026-02-23 |
| 2025-09-30 | $40.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $70.40M derived: sum of 2 quarters · filed 2025-11-03 | $113.00M 10-Q · filed 2025-11-03 | $137.90M derived: sum of 4 quarters · filed 2026-02-23 |
| 2025-06-30 | $30.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $72.70M 10-Q · filed 2025-08-04 | $97.60M derived: sum of 3 quarters · filed 2026-02-23 | $101.30M derived: sum of 4 quarters · filed 2026-02-23 |
| 2025-03-31 | $42.60M 10-Q · filed 2025-05-05 | $67.50M derived: sum of 2 quarters · filed 2026-02-23 | $71.20M derived: sum of 3 quarters · filed 2026-02-23 | $93.70M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-12-31 | $24.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $28.60M derived: sum of 2 quarters · filed 2026-02-23 | $51.10M derived: sum of 3 quarters · filed 2026-02-23 | $58.50M 10-K · filed 2026-02-23 |
| 2024-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $26.20M derived: sum of 2 quarters · filed 2024-11-04 | $33.60M 10-Q · filed 2024-11-04 | $36.60M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $22.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $29.90M 10-Q · filed 2024-08-05 | $32.90M derived: sum of 3 quarters · filed 2026-02-23 | $33.50M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $7.40M 10-Q · filed 2024-05-06 | $10.40M derived: sum of 2 quarters · filed 2026-02-23 | $11.00M derived: sum of 3 quarters · filed 2026-02-23 | $12.80M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $3.60M derived: sum of 2 quarters · filed 2026-02-23 | $5.40M derived: sum of 3 quarters · filed 2026-02-23 | $6.20M 10-K · filed 2026-02-23 |
| 2023-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $2.40M derived: sum of 2 quarters · filed 2023-11-06 | $3.20M 10-Q · filed 2023-11-06 | $3.40M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $2.60M 10-Q · filed 2023-08-07 | $2.80M derived: sum of 3 quarters · filed 2025-02-24 | $4.60M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-03-31 | $800.00K 10-Q · filed 2023-05-08 | $1.00M derived: sum of 2 quarters · filed 2025-02-24 | $2.80M derived: sum of 3 quarters · filed 2025-02-24 | $3.80M derived: sum of 4 quarters · filed 2025-02-24 |
| 2022-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $2.00M derived: sum of 2 quarters · filed 2025-02-24 | $3.00M derived: sum of 3 quarters · filed 2025-02-24 | $6.30M 10-K · filed 2025-02-24 |
| 2022-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $2.80M derived: sum of 2 quarters · filed 2022-11-07 | $6.10M 10-Q · filed 2022-11-07 | $9.50M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $4.30M 10-Q · filed 2022-08-08 | $7.70M derived: sum of 3 quarters · filed 2024-02-26 | $11.00M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $3.30M 10-Q · filed 2022-05-09 | $6.70M derived: sum of 2 quarters · filed 2024-02-26 | $10.00M derived: sum of 3 quarters · filed 2024-02-26 | $13.90M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $6.70M derived: sum of 2 quarters · filed 2024-02-26 | $10.60M derived: sum of 3 quarters · filed 2024-02-26 | $12.60M 10-K · filed 2024-02-26 |
| 2021-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $7.20M derived: sum of 2 quarters · filed 2021-11-10 | $9.20M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $5.90M 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | $2.00M 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | $700.00K 10-K · filed 2023-02-27 | |||
| 2019-12-31 | $300.00K 10-K · filed 2022-02-24 |